<DOC>
	<DOCNO>NCT02251457</DOCNO>
	<brief_summary>The purpose study gather preliminary data determine ranolazine safe effective treatment symptom myotonia congenital , paramyotonia congenita , myotonic dystrophy type 1 . The duration study 5 week .</brief_summary>
	<brief_title>Study Ranolazine Myotonia Congenita , Paramyotonia Congenita Myotonic Dystrophy Type 1</brief_title>
	<detailed_description>Recent advance understand myotonia congenita identify potential area could possibly respond treatment drug study . The drug ranolazine ( trade name Ranexa ) FDA-approved medication treat chest pain patient heart disease . Ranolazine study mice myotonia congenita . The data animal model suggest ranolazine may improve symptom sign myotonia . All individual participate place active drug . The investigator want see drug safe take without cause many side effect people myotonia congenita , paramyotonia congenital myotonic dystrophy type 1 . Participants go The Ohio State University study visit . Participants take ranolazine four week . Participants expect total 4 study visit 2 phone call 5 week period .</detailed_description>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<mesh_term>Myotonia</mesh_term>
	<mesh_term>Myotonia Congenita</mesh_term>
	<mesh_term>Myotonic Disorders</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Diagnosis myotonia congenital , paramyotonia congenital Myotonic Dystrophy Type 1 establish genetic testing subject firstdegree relative . Clinically evident myotonia Contraindications ranolazine use : fungus infection : ketoconazole ( Nizoral ) , itraconazole ( Sporanox , Onmel ) infection : clarithromycin ( Biaxin ) depression : nefazodone HIV : nelfinavir ( Viracept ) , ritonavir ( Norvir ) , lopinavir ritonavir ( Kaletra ) , indinavir ( Crixivan ) , saquinavir ( Invirase ) . tuberculosis ( TB ) : rifampin ( Rifadin ) , rifabutin ( Mycobutin ) , rifapentine ( Priftin ) seizures : phenobarbital , phenytoin ( Phenytek , Dilantin , Dilantin‚Äê125 ) , carbamazepine ( Tegretol ) herbal supplement St. John 's wort scarring ( cirrhosis ) liver Concurrent use mexiletine , lacosamide , acetazolamide , phenytoin , quinine , procainamide , Saint John wort tocainide . Patients previously treat medication may participate . They need medication least week prior enrollment . QTc &gt; 470 m men &gt; 480 ms woman . Women pregnant breastfeed Direct family history sudden cardiac death</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Myotonia Congenita</keyword>
	<keyword>ranolazine</keyword>
	<keyword>Ohio State</keyword>
	<keyword>Open Label</keyword>
	<keyword>Paramyotonia Congenita</keyword>
	<keyword>Myotonic Dystrophy 1</keyword>
</DOC>